| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/22/2026 | ±3.3% | +0.3% | over-priced |
| 07/23/2026 | ±4.4% | +0.4% | over-priced |
| 04/23/2026 | ±2.7% | -8.3% | under-priced |
| 02/24/2026 | ±5.5% | +2.7% | over-priced |
| 10/23/2025 | ±2.2% | -0.9% | over-priced |
| 07/24/2025 | ±1.5% | -7.6% | under-priced |
| 04/24/2025 | ±2.8% | -6.6% | under-priced |
| 02/25/2025 | ±1.5% | -1.6% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $2.30 | $17.1B | $2.2B |
| Q2 FY2026 | $2.27 | $17.2B | $2.2B |
| Q1 FY2026 | $1.28 | $15.9B | $1.2B |
| Q4 FY2025 | — | $19.7B | $5.6B |
International Business Machines Corporation (IBM) reports in 86 days, with the next report estimated for 01/21/2027. Across the last 8 reports, options priced an average ±3.0% earnings move while the stock actually moved 3.5% on average — the market has been roughly fair on IBM's earnings risk. Fundamentals into the print: EPS up 25.0% year-over-year, revenue up 4.7%. QuantLogix's live 5-factor engine currently reads IBM as a neutral at 53/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →